Biologia em diferentes temperaturas e ocorrência de Prorops nasuta Wat. e Cephalomia stephanoderis Betr. (Hymenoptera: Bethlydae) parasitando Hypothenemus Hampei (Ferr.) (Coleoptera: Scolytidae)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Reuerendi Patris F. Ieronymi Sauonarole de Ferr[ariis] ordinis predicatorum expositio in ps[almum].

Capitulares grab. xil.

Memoria del brigadier general Pedro Ferré, octubre de 1821 a diciembre de 1842; contribución a la historia de la provincia de Corrientes en sus luchas por la libertad y contra la tiranía.

"Consideraciones complementarias del editor," signed V. Virasoro: p. [963]-983.

Lilii Gregorii Gyraldi Ferr[aresi] Liber aduersus ingratos ; in quo multiplices ingrati criminis radices conuelluntur, variisque tum historijs, tum naturae exemplis ingrati refelluntur.

Edit16,

I. Sever. Pinæi Carnut. De integritatis et corruptionis virginum notis : graviditate item & partu naturali mulierum, opuscula ; II. Ludov. Bonacioli Ferr. Enneas muliebris ; III. Fel. Plateri Basil. De origine partium, earumque in utero conformatione ; IV. Petri Gassendi De septo cordis pervio, observatio ; V. Melchioris Sebizii De notis virginitatis ...

Extra engraved title-page, with imprint: Lugud. Batavor. : Apud Adrianum VVijngaerden, & Franciscum Moyarden, 1641.

De Rosario Ferré à Mayra Santos Febres : hacia otra forma de narrar la marginalidad

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

De Rosario Ferré à Mayra Santos Febres : hacia otra forma de narrar la marginalidad

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Médicos, advogados e indústria farmacêutica na judicialização da saúde em Minas Gerais, Brasil

OBJETIVO: Descrever as relações entre médico prescritor, advogado e indústria farmacêutica em ações judiciais contra o Estado. MÉTODOS: Estudo descritivo retrospectivo com base nas informações dos expedientes administrativos dos processos judiciais com demandas por medicamentos contra o Estado de Minas Gerais movidos entre outubro de 1999 e outubro de 2009. As variáveis estudadas foram: sexo, idade e doença dos beneficiários das ações, origem do atendimento médico (público ou privado), médico prescritor, tipo de representação jurídica e medicamento solicitado. Foi realizada análise descritiva das variáveis com a distribuição de frequências. RESULTADOS: Foram analisadas 2.412 ações judiciais referentes a 2.880 medicamentos solicitados, com 18 fármacos diferentes. Entre esses, 12 são fornecidos pelas políticas de assistência farmacêutica do Sistema Único de Saúde (SUS). Os medicamentos mais solicitados foram adalimumabe, etanercepte, infliximabe e insulina glargina. As principais doenças dos beneficiários foram artrite reumatóide, espondilite anquilosante, diabetes mellitus e doenças pulmonares obstrutivas crônicas. Houve predomínio de representação por advogados particulares e atendimento por médicos do setor privado. Entre as ações representadas pelo escritório A, 43,6% tiveram um único médico prescritor para o adalimumabe e 29 médicos foram responsáveis por 40,2% dos pedidos do mesmo fármaco. Apenas um médico foi responsável por 16,5% das prescrições de adalimumabe, solicitado por apenas um escritório particular de advocacia, em 44,8% dos pedidos. CONCLUSÕES: A maior representatividade de médicos do setor privado e advogados particulares pode trazer prejuízo à equidade. Os dados sugerem associação entre médicos e escritórios de advocacia nas solicitações dos medicamentos. Esse quadro é um indício de que a Justiça e a medicina têm sido utilizadas para atender aos interesses da indústria farmacêutica.

Legal and health variations in drug litigation injunctions granted in Minas Gerais

OBJECTIVE To investigate the factors related to the granting of preliminary court orders [injunctions] in drug litigations. METHODS A retrospective descriptive study of drug lawsuits in the State of Minas Gerais, Southeastern Brazil, was conducted from October 1999 to 2009. The database consists of 6,112 lawsuits, out of which 6,044 had motions for injunctions and 5,167 included the requisition of drugs. Those with more than one beneficiary were excluded, which totaled 5,072 examined suits. The variables for complete, partial, and suppressed motions were treated as dependent and assessed in relation to those that were independent – lawsuits (year, type, legal representation, defendant, court in which it was filed, adjudication time), drugs (level five of the anatomical therapeutic chemical classification), and diseases (chapter of the International Classification of Diseases). Statistical analyses were performed using the Chi-square test. RESULTS Out of the 5,072 lawsuits with injunctions, 4,184 (82.5%) had the injunctions granted. Granting varied from 95.8% of the total lawsuits in 2004 to 76.9% in 2008. Where there was legal representation, granting exceeded 80.0% and in lawsuits without representation, it did not exceed 66.9%. In public civil actions (89.1%), granting was higher relative to ordinary lawsuits (82.8%) and injunctions (80.1%). Federal courts granted only 68.6% of the injunctions, while the state courts granted 84.8%. Diseases of the digestive system and neoplasms received up to 87.0% in granting, while diseases of the nervous system, mental and behavioral disorders, and diseases of the skin and subcutaneous tissue received granting below 78.6% and showed a high proportion of suspended injunctions (10.9%). Injunctions involving paroxetine, somatropin, and ferrous sulfate drugs were all granted, while less than 54.0% of those involving escitalopram, sodium diclofenac, and nortriptyline were granted. CONCLUSIONS There are significant differences in the granting of injunctions, depending on the procedural and clinical variances. Important trends in the pattern of judicial action were observed, particularly, in the reduced granting [of injunctions] over the period.

Organizational culture in cooperatives: an exploratory approach

In recent years, organizational culture has become one of the common themes of interest of scientific and academic research. Each organization has its own unique cultural identity. Based on the recognition that organizational culture is considered important to an organization’s results, and social economy organizations are concerned with improving managerial practices and results, our objective is to study organizational culture in cooperatives: identifying their organizational culture as a specific type of organization of the social economy, recognized as increasingly important economic agents; and in doing so, explore the usage of a widely known model, the Competing Values Framework (Quinn & Rohrbaugh 1983). Three cooperatives were studied. Their presidents were interviewed, and a questionnaire was applied to cooperative members to obtain demographic and organizational culture data. Differences between the cooperatives’ cultural profiles seem to be consistent with both the circumstances of Portuguese social economy organizations (SEOs), and to the organizations’ uniqueness regarding their trade, focuses, and history. International firm trends were compared with this study’s results, and also appear to be explained by the SEO’s management practices evolution standpoint: lack of structured way of working, and the need to improvise and innovate in order to get things done. The importance of our research is held in the fact that social economy, and the cooperative movement in particular, has a developing importance in the expansion of many economies, the lack of literature on culture in SEOs, and the exploratory usage of a well-known model of management literature in cooperatives.